Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Nicotinamide Riboside

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03432871Not ApplicableCompleted

Nicotinamide Riboside and Mitochondrial Biogenesis

Showing all 1 trials

Research Network

Common Treatments

  • Nicotinamide Riboside1

Active Sponsors

  • Medical Research Council Mitochondrial Biology Unit1
  • University of Cambridge1
  • Cambridge University Hospitals NHS Foundation Trust1

Top Investigators

Related Conditions

  • Melas1
  • Progressive Ophthalmoplegia1
  • Mitochondrial Diseases1
  • Mitochondrial Myopathies1
  • Mitochondria Dna Deletion1

Activity Timeline